Mark Oliver

Mark Oliver is an experienced pharmaceutical sales professional with a robust background spanning over two decades. Currently serving as a Specialty Sales Representative at IBSA USA since July 2023, Mark has previously held the same position at Idorsia Pharmaceuticals Ltd from July 2022 to March 2023. Prior to that, Mark was with AstraZeneca for nearly 18 years, where responsibilities included Cardiovascular Sales Specialist and Diabetes Sales Specialist, among other roles. Mark began a career in pharmaceutical sales at PDI, Inc., focusing on primary care and specialty sales in psychiatry. Mark holds a Master of Business Administration (MBA) from Le Moyne College, specializing in Business, Management, Marketing, and Related Support Services.